EHC vs NHC Stock Comparison

Encompass Health and National Healthcare Prices as of Nov 13, 2026 Peers: Industry group
EHC Encompass Health Corp
$140.97 +11.4% 1M +23.4% 1Y
Market cap
$13.83B
P/E
21.5x
Revenue (TTM)
$6.34B
Div. yield
0.55%
Hospitals Healthcare
7 wins
NHC National Healthcare Corp
$208.19 -11.3% 1M +64.4% 1Y
Market cap
$3.26B
P/E
28.4x
Revenue (TTM)
$1.58B
Div. yield
1.26%
Home Health and Senior Care Healthcare
4 wins

Head to Head

11 decided of 12

Encompass Health leads on 7 of the 12 questions below (Encompass Health 7, National Healthcare 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionEHCNHCLeader
Larger companyMarket capitalisation $13.83B $3.26B EHC
Cheaper on earningsLower P/E, profitable companies only 21.5x 28.4x EHC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 23.1x — –
Faster revenue growthRevenue growth, trailing twelve months +9.4% +5.6% EHC
More profitableNet margin, trailing twelve months 10.2% 7.2% EHC
Better return on capitalReturn on invested capital 11.8% 8.6% EHC
Less leveragedLower net debt / EBITDA 2.0x 1.4x NHC
Higher dividend yieldTrailing dividend yield 0.55% 1.26% NHC
Better 1-year returnPrice return, last 12 months +23.4% +64.4% NHC
Better 5-year returnAnnualised price return, 5 years +17.2%/yr +23.3%/yr NHC
Less volatileAnnualised volatility, 1 year 30.1% 34.6% EHC
Higher overall scoreMean of the five percentile scores vs peers 65/100 61/100 EHC

Percentile Scorecard

EHCNHC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisEHCNHC
Valuation 67 #33 of 99 50 #50 of 99
Growth 53 #42 of 89 52 #43 of 89
Profitability 95 #6 of 92 75 #24 of 92
Financial Health 35 #67 of 103 69 #33 of 103
Shareholder Returns 76 #16 of 63 60 #26 of 63
Overall 65 61
  • EHC ranked among 103 companies in Healthcare Providers
  • NHC ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodEHCNHCSPY
1 month +11.4%-11.3% -2.0%
3 months +14.1%-6.5% -2.8%
6 months +32.2%+7.5% +2.0%
Year to date +32.8%+51.9% +10.6%
1 year +23.4%+64.4% +12.2%
3 years +118.0%+177.8% +68.1%
3 years, per year +29.7%+40.6% +18.9%
5 years +120.6%+184.3% +61.4%
5 years, per year +17.2%+23.3% +10.1%
10 years +256.2%+208.3% +248.5%
10 years, per year +13.5%+11.9% +13.3%

Risk

MeasureEHCNHCSPY
Volatility, 1Y 30.1%34.6% 13.6%
Downside volatility, 1Y 23.3%32.0% 13.9%
Beta vs S&P 500, 1Y -0.010.20 1.00
Return / volatility, 1Y 0.781.86 0.90
Max drawdown, 5Y -39.1%-34.4% -25.4%
From 52-week high -1.1%-15.8% -3.2%
52-week high $142.50$247.31 $779.14
52-week low $93.83$124.93 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleEHCNHC
P/E now vs peer median 21.5xmedian 22.4x 28.4xmedian 22.4x
P/S now vs peer median 2.2xmedian 1.3x 2.1xmedian 1.3x
EV/EBITDA now vs peer median 13.0xmedian 14.2x 17.4xmedian 14.2x
P/FCF now vs peer median 30.3xmedian 19.0x -8.4xmedian 19.0x
P/B now vs peer median 3.9xmedian 2.6x 2.9xmedian 2.6x
PEG now vs peer median 0.94median 0.84 0.81median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsEHCNHC
Revenue $6.34B $1.58B
Gross profit $6.08B –
Operating income $901.50M $154.94M
Net income $862.30M $116.02M
Free cash flow $457.20M -$388.63M
EPS (diluted) $6.46 $7.18
Cash & equivalents $76.20M $66.80M
Total debt $2.60B $502.06M
Shares (diluted) 99.70M 15.96M
Enterprise value $14.29B $2.32B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricEHCNHC
P/E 21.5x 28.4x
P/FCF 30.3x -8.4x
P/Operating cash flow 10.6x 14.7x
P/S 2.2x 2.1x
P/B 3.9x 2.9x
P/Tangible book 4.3x 2.9x
EV/EBITDA 13.0x 17.4x
EV/EBIT 18.1x 22.9x
EV/Revenue 2.6x 2.2x
EV/FCF 35.8x -9.1x
EV/Operating cash flow 12.5x 16.0x
PEG (3Y EPS CAGR) 0.94 0.81

Growth

14 metrics
MetricEHCNHC
Revenue growth (1Y) 9.4% 5.6%
Revenue CAGR (3Y) 10.5% 12.8%
Gross profit growth (1Y) 9.6% –
Gross profit CAGR (3Y) 10.7% –
Operating income growth (1Y) 20.2% 24.8%
Operating income CAGR (3Y) 21.1% 49.8%
Net income growth (1Y) 19.7% 12.2%
Net income CAGR (3Y) 23.2% 39.3%
EPS growth (1Y) 22.2% 11.1%
EPS CAGR (3Y) 22.8% 35.0%
Operating cash flow growth (1Y) 17.6% 22.5%
Operating cash flow CAGR (3Y) 16.6% 31.5%
Free cash flow growth (1Y) 13.6% -364.6%
Free cash flow CAGR (3Y) 23.7% -94.5%

Profitability

14 metrics
MetricEHCNHC
Gross margin 95.9% –
EBITDA margin 19.9% 12.9%
Operating margin 14.2% 9.8%
Pretax margin 16.8% 9.5%
Net margin 10.2% 7.2%
FCF margin 7.2% -24.5%
Operating cash flow margin 20.6% 14.0%
Return on equity 25.0% 10.3%
Return on assets 11.5% 6.4%
Return on invested capital 11.8% 8.6%
Return on capital employed 13.7% 10.2%
Asset turnover 0.8x 0.9x
Cash conversion (OCF / net income) 1.5x 1.9x
Stock comp / revenue 0.9% 0.4%

Financial Health

11 metrics
MetricEHCNHC
Debt / assets 34.4% 24.3%
Debt / equity 0.7x 0.4x
Net debt / EBITDA 2.0x 1.4x
Debt / FCF 5.7x -1.3x
Liabilities / assets 53.7% 45.3%
Equity / assets 46.3% 54.7%
Interest coverage 7.1x 19.2x
Current ratio 1.1x 1.5x
Quick ratio 0.8x 1.2x
Cash ratio 0.1x 0.8x
Altman Z-score – 3.78

Shareholder Returns

7 metrics
MetricEHCNHC
Dividend yield 0.6% 1.3%
Net buyback yield 2.0% 0.1%
Shareholder yield 2.6% 1.4%
Payout ratio (earnings) 8.9% 34.8%
Payout ratio (FCF) 16.8% -10.4%
Dividend growth (1Y) 11.3% 5.7%
Dividend CAGR (3Y) 8.4% 4.6%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusEHCNHC
Forward P/E 23.1xFY2026 –
EPS, next fiscal year $6.10FY2026 –
EPS growth, next FY +11.9%FY2026 –
EPS growth, the year after +7.5% –
Revenue, next fiscal year $6.63BFY2026 –
Revenue growth, next FY +11.7%FY2026 –
Revenue growth, the year after +9.4% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersEHCNHC
Held by institutions 96.0% 65.3%
Institutions holding 597 250
Change in shares held, QoQ -0.8% -0.6%
Institutions buying 291 136
Institutions selling 217 72
Buyers to sellers 1.34 1.89

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

EHCNHC
EHC 1.00 0.25
NHC 0.25 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, EHC and NHC?

Encompass Health (EHC) is the largest by market capitalisation: Encompass Health (EHC) $13.83B, National Healthcare (NHC) $3.26B.

Which stock is cheaper, EHC and NHC?

Encompass Health (EHC) trades on the lowest price-to-earnings ratio (Encompass Health (EHC) 21.5x, National Healthcare (NHC) 28.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Encompass Health (EHC) grew revenue fastest over the trailing twelve months: Encompass Health (EHC) +9.4%, National Healthcare (NHC) +5.6%.

Which company is more profitable?

Encompass Health (EHC) has the highest net margin (Encompass Health (EHC) 10.2%, National Healthcare (NHC) 7.2%). On return on invested capital, Encompass Health (EHC) leads (Encompass Health (EHC) 11.8%, National Healthcare (NHC) 8.6%).

Which stock has performed better?

Over the past year National Healthcare (NHC) returned the most: Encompass Health (EHC) +23.4%, National Healthcare (NHC) +64.4%. Over five years, National Healthcare (NHC) compounded fastest (Encompass Health (EHC) +17.2%/yr, National Healthcare (NHC) +23.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

National Healthcare (NHC) has the highest dividend yield: Encompass Health (EHC) 0.55%, National Healthcare (NHC) 1.26%.

Which stock is riskier?

By one-year price volatility, Encompass Health (EHC) has been the steadiest (Encompass Health (EHC) 30.1%, National Healthcare (NHC) 34.6%). Volatility measures how widely the price swings, not the risk of the business.

Do EHC and NHC move together?

Their daily returns over the past year have a correlation of 0.25, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, EHC and NHC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Encompass Health (EHC) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.